Fact CheckerSign in

NCT06959927Completed

Risk Factors and Application of Risk Management Strategies in Hemodialysis Patients Complicated With Heart Failure

Source: ClinicalTrials.gov · Last updated 7 May 2025

Brief summary (registry, in English)

Age, hyperglycemia, inflammation, and comorbidities (hypertension, diabetes, coronary disease) independently increase HF risk in hemodialysis patients. Targeted risk management reduces psychological distress, complications, and enhances care outcomes.

Status (registry)
Completed
Study type
Interventional
Enrollment
170 (actual)
First submitted
27 Mar 2025
Start date
1 Jan 2022
Primary completion date
1 Jan 2024
Lead sponsor
Guiren Hou
NCT number
NCT06959927

What you commit to

  • Study type: Interventional
  • Participants enrolled: 170
  • From 1 Jan 2022 to the primary completion date, 1 Jan 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients were excluded if they had severe liver diseases (e.g., cirrhosis or liver failure), significant systemic infections, active tuberculosis, malignant tumors, connective tissue diseases, or other major illnesses.
    • Patients with congenital kidney diseases, congenital heart defects, or other severe congenital structural abnormalities were excluded.
    • Patients who had a documented history of severe cardiac diseases were excluded, including those with primary/secondary cardiomyopathy, valvular heart disease, myocarditis, or pericardial diseases.
    • Patients were excluded if they had severe mental disorders or cognitive impairments that prevented their cooperation with study assessments or treatments.
    • ⑤Patients whose clinical records or examination data were incomplete, thereby precluding effective analysis, were excluded.

Who the study is looking for

  • Patients were aged 18 years or older who had been undergoing regular hemodialysis treatment for more than three months.
    • Patients were in good cardiopulmonary health without severe acute or chronic diseases, and were capable of undergoing the study-related examinations and treatments.
    • Patients had not undergone major surgeries or experienced acute complications within the three months prior to enrollment, and their conditions were stable.
    • Patients demonstrated high compliance by following medical advice and regularly attending dialysis sessions and related examinations.
    • ⑤Patients were able to understand the study objectives, had signed the informed consent form, and were willing to cooperate with follow-up visits and long-term observation.

Age in the registry: 38 years to 68 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Changsha Fourth Hospital
Coordinator of this site? Confirm its status
ChangshaChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.